Immunopathology of Hepatitis B Virus Infection

REFERENCES

• Rehermann B., Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215–229
   PubMed Web of Science ®Google Scholar
• Gambarin-Gelwan M. Hepatitis B in pregnancy. Clin Liver Dis 2007; 11: 945–963
   PubMedGoogle Scholar
• Martin-Vilchez S. P., Sanz-Cameno Y., Rodriguez-Munoz Majano P. L., Molina-Jimenez F. M., Lopez-Cabrera Moreno-Otero R., Lara-Pezzi E. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 2008; 47: 1872–1883
   PubMedGoogle Scholar
• Nassal M., Schaller H. Hepatitis B virus replication—an update. J Viral Hepat 1996; 3: 217–226
   PubMed Web of Science ®Google Scholar
• Lu C. Y., Ni Y. H., Chiang B. L., Chen P. J., Chang M. H., Chang L. Y., Su I. J., Kuo H. S., Huang L. M., Chen D. S., Lee C. Y. Humoral and cellular immune responses to a hepatitis B vaccine booster 15–18 years after neonatal immunization. J Infect Dis 2008; 197: 1419–1426
   PubMed Web of Science ®Google Scholar
• Ganem D., Prince A. M. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med 2004; 350: 1118–1129
   PubMed Web of Science ®Google Scholar
• Stevens C. E., Beasley R. P., Tsui J., Lee W. C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771–774
   PubMed Web of Science ®Google Scholar
• Bruss V. Envelopment of the hepatitis B virus nucleocapsid. Virus Res 2004; 106: 199–209
   Google Scholar
• Summers J., O'Connell A., Millman I. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci USA 1975; 72: 4597–4601
   PubMed Web of Science ®Google Scholar
• Huang C. F., Lin S. S., Ho Y. C., Chen F. L., Yang C. C. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol 2006; 3: 97–106
   PubMed Web of Science ®Google Scholar
• Ganem D. Assembly of hepadnaviral virions and subviral particles. Curr Top Microbiol Immunol 1991; 168: 61–83
   PubMed Web of Science ®Google Scholar
• Klingmuller U., Schaller H. Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor. J Virol 1993; 67: 7414–7422
   PubMed Web of Science ®Google Scholar
• Ganem Virology D. The X files—one step closer to closure. Science 2001; 294: 2299–2300
   Google Scholar
• Nassal M. Hepatitis B viruses: reverse transcription a different way. Virus Res 2008; 134: 235–249
   PubMed Web of Science ®Google Scholar
• Guidotti L. G., Chisari F. V. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 2006; 1: 23–61
   PubMed Web of Science ®Google Scholar
• Pungpapong S., Kim W. R., Poterucha J. J. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 2007; 82: 967–975
   PubMed Web of Science ®Google Scholar
• Kim M. J., Kwon O. S., Chung N. S., Lee S. Y., Jung H. S., Park D. K., Ku Y. S., Kim Y. K., Kim Y. S., Kim J. H. The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis. Korean J Hepatol 2008; 14: 67–76
   Google Scholar
• But D. Y., Lai C. L., Yuen M. F. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol 2008; 14: 1652–1656
   PubMed Web of Science ®Google Scholar
• Hoar D. I., Bowen T., Matheson D., Poon M. C. Hepatitis B virus DNA is enriched in polymorphonuclear leukocytes. Blood 1985; 66: 1251–1253
   PubMedGoogle Scholar
• Fawaz L. M., Sharif-Askari E., Menezes J. Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. J Immunol 1999; 163: 4473–4480
   Web of Science ®Google Scholar
• Biron C. A., Nguyen K. B., Pien G. C., Cousens L. P., Salazar-Mather T. P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189–220
   PubMed Web of Science ®Google Scholar
• Ranson T., Vosshenrich C. A., Corcuff E., Richard O., Muller W., Di-Santo J. P. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 2003; 101: 4887–4893
   PubMed Web of Science ®Google Scholar
• de Lalla C., Festuccia N., Albrecht I., Chang H. D., Andolfi G., Benninghoff U., Bombelli F., Borsellino G., Aiuti A., Radbruch A., Dellabona P., Casorati G. Innate-like effector differentiation of human invariant NKT cells driven by IL-7. J Immunol 2008; 180: 4415–4424
   Google Scholar
• Parekh V. V., Lalani S., Van L. K. The in vivo response of invariant natural killer T cells to glycolipid antigens. Int Rev Immunol 2007; 26: 31–48
   Web of Science ®Google Scholar
• Ranson T., Vosshenrich C. A., Corcuff E., Richard O., Laloux V., Lehuen A., Di Santo J. P. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc Natl Acad Sci USA 2003; 100: 2663–2668
   PubMed Web of Science ®Google Scholar
• Sitia G., Isogawa M., Iannacone M., Campbell I. L., Chisari F. V., Guidotti L. G. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J Clin Invest 2004; 113: 1158–1167
   PubMed Web of Science ®Google Scholar
• Ando K., Guidotti L. G., Wirth S., Ishikawa T., Missale G., Moriyama T., Schreiber R. D., Schlicht H. J., Huang S. N., Chisari F. V. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 1994; 152: 3245–3253
   PubMed Web of Science ®Google Scholar
• Tsui L. V., Guidotti L. G., Ishikawa T., Chisari F. V. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc Natl Acad Sci USA 1995; 92: 12398–12402
   Google Scholar
• Chen Y., Wei H., Gao B., Hu Z., Zheng S., Tian Z. Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepat 2005; 12: 38–45
   PubMedGoogle Scholar
• de Lalla C., Galli G., Aldrighetti L., Romeo R., Mariani M., Monno A., Nuti S., Colombo M., Callea F., Porcelli S. A., Panina-Bordignon P., Abrignani S., Casorati G., Dellabona P. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 2004; 173: 1417–1425
   PubMed Web of Science ®Google Scholar
• Fischler B., Nystrom J., Bjornsdottir T., Lindh G., Hultgren C. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection. J Pediatr Gastroenterol Nutr 2007; 45: 75–83
   Google Scholar
• Michalak T. I., Hodgson P. D., Churchill N. D. Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection. J Virol 2000; 74: 4483–4494
   PubMed Web of Science ®Google Scholar
• Guidotti L. G., Chisari F. V. To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996; 8: 478–483
   Google Scholar
• Yuen M. F., Wong D. K., Zheng B. J., Chan C. C., Yuen J. C., Wong B. C., Lai C. L. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion. J Viral Hepat 2007; 14: 269–275
   PubMedGoogle Scholar
• Ma K., Xu W., Shao Yanyue X., Hu L., Xu H., Yuan Z., Zheng X., Xiong S. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells. Antiviral Res 2007; 76: 140–149
   PubMed Web of Science ®Google Scholar
• Cooksley H., Chokshi S., Maayan Y., Wedemeyer H., Andreone P., Gilson R., Warnes T., Paganin S., Zoulim F., Frederick D., Neumann A. U., Brosgart C. L., Naoumov N. V. Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity. Antimicrob Agents Chemother 2008; 52: 312–320
   PubMed Web of Science ®Google Scholar
• Li J., Wang J., Tian K., Wang Y., Zhang L., Huang H. Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users. J. Huazhong Univ Sci Technol Med Sci 2006; 26: 221–224
   Google Scholar
• Forsthuber T., Yip H. C., Lehmann P. V. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996; 271: 1728–1730
   PubMed Web of Science ®Google Scholar
• Barrios C., Brawand P., Berney M., Brandt C., Lambert P. H., Siegrist C. A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 1996; 26: 1489–1496
   Google Scholar
• Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348–2357
   PubMed Web of Science ®Google Scholar
• Paludan S. R. Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship. Scand J Immunol 1998; 48: 459–468
   PubMed Web of Science ®Google Scholar
• Billiau A. Interferon-gamma: biology and role in pathogenesis. Adv Immunol 1996; 62: 61–130
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138–146
   PubMedGoogle Scholar
• Seder R. A., Paul W. E. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994; 12: 635–673
   PubMed Web of Science ®Google Scholar
• Kim S. H., Kim S. H., Oh H. K., Ryu C. J., Park S. Y., Hong H. J. In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees. Exp Mol Med 2008; 40: 145–149
   Google Scholar
• Burton D. R., Williamson R. A., Parren P. W. Antibody and virus: binding and neutralization. Virology 2000; 270: 1–3
   Google Scholar
• Kakimi K., Lane T. E., Wieland S., Asensio V. C., Campbell I. L., Chisari F. V., Guidotti L. G. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 2001; 194: 1755–1766
   PubMed Web of Science ®Google Scholar
• Falasca K., Ucciferri C., Dalessandro M., Zingariello P., Mancino P., Petrarca C., Pizzigallo E., Conti P., Vecchiet J. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci 2006; 36: 144–150
   PubMed Web of Science ®Google Scholar
• Heijtink R. A., Janssen H. L., Hop W. C., Osterhaus A. D., Schalm S. W. Interferon-alpha therapy for chronic hepatitis B: early response related to pre-treatment changes in viral replication. J Med Virol 2001; 63: 217–219
   PubMed Web of Science ®Google Scholar
• Marotta F., Vangieri B., Cecere A., Gattoni A. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect. Clin Ter 2004; 155: 187–199
   Google Scholar
• Chisari F. V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29–60
   PubMed Web of Science ®Google Scholar
• Tsai T. H., Huang C. F., Wei J. C., Ho M. S., Wang L., Tsai W. Y., Lin C. C., Xu F. L., Yang C. C. Study of IgG subclass profiles of anti-HBs in populations with different HBV infection status. Viral Immunol 2006; 19: 277–284
   Google Scholar
• Yang Y. Y., Huang C. F., Wei J. C., Ho M. S., Wang L. N., Lin S. J., Tsai W. Y., Lin C. C., Xu F., Yang C. C. The study of IgG subclass profiles of anti-hbc in populations with different status of HBV infection. Cell Mol Immunol 2005; 2: 393–408
   Google Scholar
• Wang L., Lin S. J., Tsai J. H., Tsai C. H., Tsai C. C., Yang C. C. Anti-hepatitis B surface antigen IgG1 subclass is predominant in individuals who have recovered from hepatitis B virus infection, chronic carriers, and vaccines. Med Microbiol Immunol 2005; 194: 33–38
   Google Scholar
• Hoofnagle J. H. Serologic markers of hepatitis B virus infection. Annu Rev Med 1981; 32: 1–11
   PubMed Web of Science ®Google Scholar
• Borzi R. M., Dal Monte P., Honorati M. C., Facchini A. IgG subclass distribution of anti-HBs antibodies following vaccination with cDNA HBsAg. J Immunol Methods 1992; 146: 17–23
   PubMedGoogle Scholar
• Zinkernagel R. M. Immunology taught by viruses. Science 1996; 271: 173–178
   PubMed Web of Science ®Google Scholar
• Carotenuto P., Quinti I., Pontesilli O., Hall A. J., DeLange G. G., Whittle H. C., D'Amelio R., Aiuti F. Response to hepatitis B vaccine in a cohort of Gambian children. Pediatr Infect Dis J 1995; 14: 215–220
   Google Scholar
• Morell A., Roth-Wicky B., Skvaril F. Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen. Infect Immun 1983; 39: 565–568
   Google Scholar
• Yang C. C., Lin C. C., Wang L., Ku C. S., Chen C. K. Anti-HBc IgG subclasses in different populations by comparing a variety of ELISA plates. J Immunoassay Immunochem 2001; 22: 33–45
   PubMed Web of Science ®Google Scholar
• Wang L., Tsai T. H., Huang C. F., Ho M. S., Lin D. B., Ho Y. C., Lin S. S., Wei J. C., Chou M. C., Yang C. C. Utilizing self-prepared ELISA plates for a cross-population study of different anti-HBe IgG subclass profiles. J Med Virol 2007; 79: 495–502
   Google Scholar
• Townsend K., Sallberg M., O'Dea J., Banks T., Driver D., Sauter S., Chang S. M., Jolly D. J., Mento S. J., Milich D. R., Lee W. T. Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens. J Virol 1997; 71: 3365–3374
   PubMed Web of Science ®Google Scholar
• Torgano G., Vecchi M., Podda M., Zuin M., Arosio E., Battezzati P. M., de Franchis R. Primary biliary cirrhosis is associated with specific changes in liver IgG-bearing cell subpopulations. J Hepatol 1995; 22: 545–550
   PubMedGoogle Scholar
• Akbar S. M., Horiike N., Onji M., Ohta Y. Immunoglobulin G subclasses of antibodies to hepatitis B core antigen in HBs antigen positive liver diseases. J Gastroenterol Hepatol 1991; 6: 71–76
   PubMedGoogle Scholar
• Sallberg M., Norder H., Magnius L. O. Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B. J Med Virol 1990; 30: 1–6
   PubMedGoogle Scholar
• Skvaril F., Joller-Jemelka H. IgG subclasses of anti-HBs antibodies in vaccinated and nonvaccinated individuals and in anti-HBs immunoglobulin preparations. Int Arch Allergy Appl Immunol 1984; 73: 330–337
   PubMedGoogle Scholar
• Gregorek H., Madalinski K., Woynarowski M., Mikolajewicz J., Syczewska M., Socha J. IgG subclass distribution of hepatitis B surface antigen antibodies induced in children with chronic hepatitis B infection after interferon-α therapy. J Infect Dis 2000; 181: 2059–2062
   Google Scholar
• Gregorek H., Dzieranowska-Fangrat K., Woynarowski M., Jówiak P., Witkowska-Vogtt E., Socha J., Syczewska M., Madaliñski K. Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-α therapy: correlation with specific IgG subclass responses to HBsAg. J Hepatol 2005; 42: 486–490
   PubMed Web of Science ®Google Scholar
• van Loon A. M., Heessen F. W., van der Logt J. T. Antibody isotype response after human cytomegalovirus infection. J Virol Methods 1987; 15: 101–107
   Google Scholar
• Carricart S. E., Bustos D., Biganzoli P., Nates S. E., Pavan J. V. Isotype immune response of IgG antibodies at the persistence and reactivation stages of human herpes virus 6 infection. J Clin Virol 2004; 31: 266–269
   Google Scholar
• Jenison S., Yamada T., Morris C., Anderson B., Torrez-Martinez N., Keller N., Hjelle B. Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol 1994; 68: 3000–3006
   PubMed Web of Science ®Google Scholar
• Lundkvist A., Bjorsten S., Niklasson B. Immunoglobulin G subclass responses against the structural components of Puumala virus. J Clin Microbiol 1993; 31: 368–372
   PubMed Web of Science ®Google Scholar
• Khalife J., Guy B., Capron M., Kieny M. P., Ameisen J. C., Montagnier L., Lecocq J. P., Capron A. Isotypic restriction of the antibody response to human immunodeficiency virus. AIDS Res Hum Retroviruses 1988; 4: 3–9
   Google Scholar
• Linde A., Sundqvist V. A., Mathiesen T., Wahren B. IgG subclasses to subviral components. Monogr Allergy 1988; 23: 27–32
   Google Scholar
• Wagner D. K., Nelson D. L., Walsh E. E., Reimer C. B., Henderson F. W., Murphy B. R. Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults. J Clin Microbiol 1987; 25: 748–750
   PubMedGoogle Scholar
• Aalberse R. C., van der Gaag R., van Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 1983; 130: 722–726
   PubMed Web of Science ®Google Scholar
• Sundqvist V. A., Linde A., Wahren B. Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections. J Clin Microbiol 1984; 20: 94–98
   PubMed Web of Science ®Google Scholar
• Hsu Y. S., Chien R. N., Yeh C. T., Sheen I. S., Chiou H. Y., Chu C. M., Liaw Y. F. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002; 35: 1522–1527
   PubMed Web of Science ®Google Scholar
• Grigorescu-Sido P., Calin L., Manasia R., Mirestean S., Cret V., Skorka C., Grigorescu-Sido A. Results of interferon treatment in children with chronic hepatitis B. Rom J Gastroenterol 2002; 11: 285–290
   Google Scholar
• Bozkaya H., Bozdayi M., Turkyilmaz R., Sarioglu M., Cetinkaya H., Cinar K., Kose K., Yurdaydin C., Uzunalimoglu O. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology 2000; 47: 1675–1679
   PubMed Web of Science ®Google Scholar
• Hultgren C., Milich D. R., Weiland O., Sallberg M. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 1998; 79: 2381–2391, (Pt 10)
   PubMed Web of Science ®Google Scholar
• Rico M. A., Quiroga J. A., Subira D., Castanon S., Esteban J. M., Pardo M., Carreno V. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology 2001; 33: 295–300
   PubMed Web of Science ®Google Scholar
• Milich D. R., Chen M. K., Hughes J. L., Jones J. E. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 1998; 160: 2013–2021
   PubMed Web of Science ®Google Scholar
• Milich D. R., Schodel F., Peterson D. L., Jones J. E., Hughes J. L. Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur J Immunol 1995; 25: 1663–1672
   PubMed Web of Science ®Google Scholar
• Milich D. R., Jones J., Hughes J., Maruyama T. Role of T-cell tolerance in the persistence of hepatitis B virus infection. J Immunother Emphasis Tumor Immunol 1993; 14: 226–233
   Google Scholar
• Vanlandschoot P., Cao T., Leroux-Roels G. The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure. Antiviral Res 2003; 60: 67–74
   Web of Science ®Google Scholar
• Ishizaka S. T., Piacente P., Silva J., Mishkin E. M. IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies. J Infect Dis 1995; 172: 1108–1111
   Google Scholar
• Lynch D. H., Ramsdell F., Alderson M. R. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995; 16: 569–574
   PubMedGoogle Scholar
• Chen X., Li M., Le X., Ma W., Zhou B. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection. Vaccine 2004; 22: 439–446
   PubMedGoogle Scholar
• He X. S., Chen H. S., Chu K., Rivkina M., Robinson W. S. Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen. Proc Natl Acad Sci USA 1996; 93: 7274–7278
   Google Scholar
• Beckebaum S., Cicinnati V. R., Gerken G. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?. Rev Med Virol 2002; 12: 297–319
   Google Scholar
• Wang C. X., Wang J. F., Liu M., Zou X., Yu X. P., Yang X. J., Zheng G. X. Expression of HLA class I and II on peripheral blood lymphocytes in HBV infection. Chin Med J (Engl) 2006; 119: 753–756
   Google Scholar
• Khakoo S. I., Ling R., Scott I., Dodi A. I., Harrison T. J., Dusheiko G. M., Madrigal J. A. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals. Gut 2000; 47: 137–143
   PubMed Web of Science ®Google Scholar
• Boni C., Penna A., Ogg G. S., Bertoletti A., Pilli M., Cavallo C., Cavalli A., Urbani S., Boehme R., Panebianco R., Fiaccadori F., Ferrari C. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001; 33: 963–971
   PubMed Web of Science ®Google Scholar
• Zheng B. J., Zhou J., Qu D., Siu K. L., Lam T. W., Lo H. Y., Lee S. S., Wen Y. M. Selective functional deficit in dendritic cell–T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J Viral Hepat 2004; 11: 217–224
   PubMed Web of Science ®Google Scholar
• Yewdell J. W., Bennink J. R. Mechanisms of viral interference with MHC class I antigen processing and presentation. Annu Rev Cell Dev Biol 1999; 15: 579–606
   PubMed Web of Science ®Google Scholar
• Brunetto M. R., Giarin M. M., Oliveri F., Chiaberge E., Baldi M., Alfarano A., Serra A., Saracco G., Verme G., Will H., Bonino F. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 1991; 88: 4186–4190
   PubMed Web of Science ®Google Scholar
• Stoop J. N., van der Molen R. G., Kuipers E. J., Kusters J. G., Janssen H. L. Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. Virology 2007; 361: 141–148
   PubMed Web of Science ®Google Scholar
• Yang G., Liu A., Xie Q., Guo T. B., Wan B., Zhou B., Zhang J. Z. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol 2007; 19: 133–140
   PubMed Web of Science ®Google Scholar
• Manigold T., Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 2007; 7: 804–813
   PubMed Web of Science ®Google Scholar
• Baecher-Allan C., Hafler D. A. Suppressor T cells in human diseases. J Exp Med 2004; 200: 273–276
   PubMed Web of Science ®Google Scholar
• Jonuleit H., Schmitt E., Kakirman H., Stassen M., Knop J., Enk A. H. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 2002; 196: 255–260
   PubMed Web of Science ®Google Scholar
• Fu J. L., Xu D. P., Zhao P., Chen L. M., Zhang H., Zhou C. B., Yao J. X., Rong Y. H., Wang F. S. The characterization of regulatory T cells in peripheral blood of HBV-infected patients. Zhonghua Yi Xue Za Zhi 2006; 86: 1522–1525
   Google Scholar
• Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., Zhao J. M., Zhang B., Shi M., Ding X., Tang Z., Fu Y. X., Wang F. S. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177: 739–747
   PubMed Web of Science ®Google Scholar
• Kondo Y., Kobayashi K., Ueno Y., Shiina M., Niitsuma H., Kanno N., Kobayashi T., Shimosegawa T. Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B. World J Gastroenterol 2006; 12: 4310–4317
   PubMed Web of Science ®Google Scholar
• Chichester J. A., Feitelson M. A., Calkins C. E. Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells. Immunology 2006; 118: 438–448
   Google Scholar